30.10 12:31 | dpa-AFX: Zimmer Biomet Holdings Q3 24 Earnings Conference Call At 8:30 AM ET |
30.10 12:21 | dpa-AFX: ROUNDUP: Zimmer Biomet Reduces, And Narrows Full Year Outlook Range |
30.10 11:51 | dpa-AFX: *ZIMMER BIOMET NOW EXPECTS FY24 ADJ. EPS OF $7.95 - $8.05 |
30.10 11:51 | dpa-AFX: *ZIMMER BIOMET NOW EXPECTS FY24 REPORTED REVENUE GROWTH OF 3.5% - 4.0% |
30.10 11:49 | dpa-AFX: *ZIMMER BIOMET Q3 ADJ. EPS $1.74 VS. $1.65 LAST YEAR |
30.10 11:48 | dpa-AFX: *ZIMMER BIOMET Q3 NET SALES $1.824 BLN VS. $1.753 BLN LAST YEAR |
30.10 11:48 | dpa-AFX: *ZIMMER BIOMET Q3 OPERATING PROFIT $279.5 MLN VS. $266.6 MLN LAST YEAR |
30.10 11:48 | dpa-AFX: *ZIMMER BIOMET Q3 NET INCOME $249.1 MLN VS. $162.7 MLN LAST YEAR |
30.10 11:44 | dpa-AFX: Zimmer Biomet Holdings Inc. Q3 Profit Increases, Beats Estimates |
30.10 11:32 | dpa-AFX: *ZIMMER BIOMET Q3 EPS $1.23 VS. $0.77 LAST YEAR |
28.10 12:44 | dpa-AFX: Zimmer Biomet Announces Commercial Launch Plans For Z1 Femoral Hip System For Total Hip Arthroplasty |
28.10 12:32 | dpa-AFX: *ZIMMER BIOMET ANNOUNCED PLANS FOR COMMERCIAL LAUNCH OF Z1T FEMORAL HIP SYSTEM FOR TOTAL HIP ARTHROPLASTY |
18.09 12:32 | dpa-AFX: FDA Alerts Of High Thigh Fracture Risk With Zimmer Biomet's Hip Replacement Device |
06.09 14:19 | dpa-AFX: Zimmer Biomet Holdings To Present At Morgan Stanley Healthcare Conference; Webcast At 9:15 AM ET |
05.09 13:35 | dpa-AFX: *ZIMMER BIOMET APPOINTS DAVID DEMARTINO AS SVP, INVESTOR RELATIONS |
05.09 13:14 | dpa-AFX: Zimmer Biomet Holdings To Present At Wells Fargo Healthcare Conference; Webcast At 8:00 AM ET |
29.08 22:49 | dpa-AFX: *ZIMMER BIOMET DECLARES QUARTERLY DIVIDEND OF $0.24/SHARE, PAYABLE OCT. 31/ RECORD SEPT. 30 |
29.08 22:46 | dpa-AFX: *ZIMMER BIOMET HOLDINGS INC. (ZBH) DECLARES $ 0.24 DIVIDEND FOR Q3 24, RECORD DATE 9/30/2024 |
07.08 13:32 | dpa-AFX: Zimmer Biomet Holdings Q2 24 Earnings Conference Call At 8:30 AM ET |
07.08 13:09 | dpa-AFX: ROUNDUP: Zimmer Biomet Trims FY24 Revenue Growth Outlook; To Acquire OrthoGrid Systems |
|